TABLE 2

Metabolic parameters of diabetic patients after rosiglitazone and placebo treatments

VariablesPlacebo groupRosiglitazone group
n2323
BMI (kg/m2)27.9 ± 729.1 ± 5
Systolic blood pressure (mmHg)126 ± 13126 ± 15
Diastolic blood pressure (mmHg)82 ± 680 ± 4
A1C (%)7.3 ± 1.57.3 ± 1.8
Blood glucose (mmol/l)8.1 ± 1.7*8.1 ± 1.9*
Insulin (μU/ml)10.6 ± 2.710.4 ± 2.9
HOMA-IR4.47 ± 1.53.51 ± 1.2*
CRP (mg/dl)1.1 ± 0.070.77 ± 0.09*
Total cholesterol (mmol/l)5.61 ± 0.115.69 ± 0.14
HDL cholesterol (mmol/l)1.24 ± 0.091.29 ± 0.1
Triglycerides (mmol/l)1.85 ± 0.321.89 ± 0.36
  • Data are means ± SD.

  • *

    * P < 0.05 vs. baseline data;

  • P < 0.05 vs. the placebo group.